Aug 19, 2009
(CIDRAP News) – The US Food and Drug Administration (FDA) today approved a vaccine filling and packaging facility in Illinois owned by CSL Biotherapies, one of the five companies under contract to make novel H1N1 vaccines for the United States, the company announced.
(CIDRAP News) Half a century ago, scientists reported evidence of some curious behavior by the immune system in humans and animals: If a host was exposed to an influenza virus and later encountered a variant strain of the same virus, the immune system responded to the second attack largely with the same weapons it used against the first one.
(CIDRAP News) Federal officials today during a pandemic H1N1 planning update dialed back the number of novel flu vaccine doses they expect in October from 120 million to 45 million, listing several reasons for the smaller projection.
(CIDRAP News) State health departments will decide which providers will administer the pandemic H1N1 influenza vaccine this fall, and a single company will be the distributor for all the doses, it was announced today.
(CIDRAP News) The World Health Organization (WHO) said today that the fast-tracking of vaccines for pandemic H1N1 influenza won't compromise safety, while acknowledging that clinical data will be limited when the first doses are administered.
(CIDRAP News) The Centers for Disease Control and Prevention (CDC) plans to gather the public's thoughts in August on how big this fall's H1N1 influenza vaccination drive should be.
(CIDRAP News) While most vaccine manufacturers have reaped below-average crops of H1N1 influenza vaccine virus from the eggs in which they're grown, MedImmune Inc. has a different problem: high virus yields, but a potential shortage of the devices used to spray the vaccine into the nose.
(CIDRAP News) The top US advisory panel on immunizations recommended today that groups totaling up to 159 million people be targeted for vaccination against the pandemic H1N1 influenza virus but that a narrower population of about 41 million have priority if initial supplies are short.
(CIDRAP News) The immunization advisory group for the US Centers for Disease Control and Prevention (CDC) meets tomorrow in an emergency session to discuss which groups should be targeted to receive the pandemic H1N1 vaccine and whether some should have priority.
